{{drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458774403
| IUPAC_name = [(''R''*,''S''*)-2,8-Bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
| image = (RS,SR)-mefloquine.svg
| chirality = [[外消旋混合物|外消旋混合物]]
| width = 275
| image2 = (RS,SR)-mefloquine ball-and-stick model.png

<!--Clinical data-->
| tradename = Lariam, Mephaquin, Mefliam
| Drugs.com = {{drugs.com|monograph|Lariam}}
| pregnancy_AU = B3
| pregnancy_US = B
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[Wiktionary:oral|By mouth]] ([[片剂|tablets]])

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 37171
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TML814419R
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 416956
| NIAID_ChemDB = 005218
| smiles = FC(F)(F)c2cccc1c(cc(nc12)C(F)(F)F)[C@H](O)[C@@H]3NCCCC3
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XEEQGYMUWCZPDN-DOMZBBRYSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 53230-10-7
| ATC_prefix = P01
| ATC_suffix = BC02
| PubChem = 40692
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00358
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04895
| C=17 | H=16 | F=6 | N=2 | O=1
| molecular_weight = 378.312 g/mol
| bioavailability =
| metabolism = Extensive [[肝臟|liver]]; main metabolite is inactive
| elimination_half-life = 2 至 4 週
| excretion = Primarily bile and feces; urine (9% as unchanged drug, 4% as primary metabolite)
}}

<!-- Definition and medical uses -->
'''美爾奎寧'''（Mefloquine），常見商品名'''瘧寧'''（Lariam），為一種治療及預防[[疟疾|疟疾]]的藥物<ref name=AHFS2015>{{cite web|title=Lariam|url=http://www.drugs.com/monograph/lariam.html|work=The American Society of Health-System Pharmacists|accessdate=27 Nov 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208110901/http://www.drugs.com/monograph/lariam.html|archivedate=2015-12-08|df=}}</ref>。當用於預防時，需在暴露瘧原蟲前一至二週開始用藥，每週一次。暴露後則須維持四週，每週一次<ref name=AHFS2015/>。本品可用於治療瘧疾的輕度症狀，但無法用於治療重症瘧疾<ref name=AHFS2015/>。本品為口服藥物<ref name=AHFS2015/>。

<!-- Side effects -->
嚴重副作用包含長期精神問題，例如[[抑郁_(情绪)|憂鬱]]、幻覺，及[[焦慮|焦慮]]等。神經方面的副作用則包含[[失調|平衡感下降]]、[[癲癇發作|癲癇發作]]，以及[[耳鸣|耳鸣]]等等<ref name=AHFS2015/>。因此本品不建議用於有精神問題或[[癲癇|癲癇]]患者<ref name=AHFS2015/>。常見副作用包含嘔吐、腹瀉、頭痛，以及紅疹<ref name=AHFS2015/>。[[妊娠|妊娠]]期間不建議用藥，除非沒有其他替代方案<ref name=AHFS2015/>。[[哺乳|哺乳]]期間亦不建議使用<ref name=AHFS2015/>。

<!-- History, society and culture -->
美爾奎寧最早由美國陸軍於1970年代開發出來，並於1980年代中期開始應用<ref name=Croft07>{{cite journal|last=Croft|first=AM|title= A lesson learnt: the rise and fall of Lariam and Halfan|journal= J R Soc Med |year=2007|volume=100|pages=170–4|pmid=17404338|issue=4|doi=10.1258/jrsm.100.4.170|pmc=1847738}}</ref><ref>{{cite book|last1=Ravina|first1=Enrique|title=The evolution of drug discovery : from traditional medicines to modern drugs|date=2011|publisher=Wiley-VCH|location=Weinheim|isbn=9783527326693|page=136|edition=1. Aufl.|url=https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA136|deadurl=no|archiveurl=https://web.archive.org/web/20151208065822/https://books.google.com/books?id=iDNy0XxGqT8C&pg=PA136|archivedate=2015-12-08|df=}}</ref><ref>{{cite book|author=Jeremy Farrar|author2=Peter J. Hotez|author3= Thomas Junghanss|title=Manson's tropical diseases.|date=2013|publisher=Elsevier/Saunders|location=Oxford|isbn=9780702053061|page=569|edition=23rd|url=https://books.google.com/books?id=GTjRAQAAQBAJ&pg=PA569|deadurl=no|archiveurl=https://web.archive.org/web/20151208061941/https://books.google.com/books?id=GTjRAQAAQBAJ&pg=PA569|archivedate=2015-12-08|df=}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。本品屬於[[通用名药物|學名藥]]<ref name=AHFS2015/>。[[发展中国家|发展中国家]]每劑批發價約介於 0.6 至 1.3 美金之間<ref>{{cite web|title=Mefloquine|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=MEF250T&s_year=2014&year=2014&str=250%20mg&desc=Mefloquine&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E5%2E3%2E2&supplement=&class_name=%2806%2E5%2E3%2E1%29Antimalarial%20medicines%2C%20for%20curative%20treatment%3Cbr%3E%2806%2E5%2E3%2E2%29Antimalarial%20medicines%2C%20for%20prophylaxis%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=27 November 2015}}{{Dead link|date=2018年6月 |bot=InternetArchiveBot |fix-attempted=no }}</ref>。在美國則約 10 美金<ref name=AHFS2015/>。

==參見==
* {{tsl|en|Somalia Affair||Somalia Affair}}

==參考文獻==
{{reflist|colwidth=30em}}

==外部連結==
{{Commons category}}
*[http://www.medicines.org.uk/EMC/medicine/1701/SPC/Lariam/ Manufacturer's information]
* [http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088616.pdf Roche Medication Guide for Lariam]
*[https://web.archive.org/web/20130725111823/http://www.lariaminfo.org/ Mefloquine (Lariam) Action, Clearinghouse for information on mefloquine news, research, toxicity]
*[http://jama.ama-assn.org/content/297/20/2251.full Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers]
*[http://www.malariajournal.com/content/9/1/357 The position of mefloquine as a 21st century malaria chemoprophylaxis] (Paper based on data collated for an F. Hoffmann-La Roche regulatory update)
* [https://www.nytimes.com/2013/08/08/opinion/crazy-pills.html?src=me&ref=general Crazy Pills - NYTimes Op-Ed ]
* [http://www.kepstein.com/2009/07/24/lariam-files/ The Lariam Files - Keith Epstein, Washington Post]

[[Category:抗疟疾剂|Category:抗疟疾剂]]
[[Category:喹啉|Category:喹啉]]
[[Category:哌啶|Category:哌啶]]
[[Category:三氟甲基化合物|Category:三氟甲基化合物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:羅氏藥廠|Category:羅氏藥廠]]